Free Trial

Bioventix (BVXP) Competitors

Bioventix logo
GBX 2,351.50 -23.50 (-0.99%)
As of 11:30 AM Eastern

BVXP vs. SLN, PRTC, HZD, AVCT, VRP, FARN, ARIX, CIR, 4BB, and TILS

Should you be buying Bioventix stock or one of its competitors? The main competitors of Bioventix include Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Avacta Group (AVCT), Verona Pharma plc (VRP.L) (VRP), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Circassia Group (CIR), 4basebio (4BB), and Tiziana Life Sciences (TILS). These companies are all part of the "biotechnology" industry.

Bioventix vs. Its Competitors

Silence Therapeutics (LON:SLN) and Bioventix (LON:BVXP) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

Bioventix has a net margin of 59.51% compared to Silence Therapeutics' net margin of 0.00%. Bioventix's return on equity of 69.09% beat Silence Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Silence TherapeuticsN/A N/A N/A
Bioventix 59.51%69.09%54.07%

32.4% of Bioventix shares are owned by institutional investors. 6.1% of Bioventix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Silence Therapeutics' average media sentiment score of 0.00 equaled Bioventix'saverage media sentiment score.

Company Overall Sentiment
Silence Therapeutics Neutral
Bioventix Neutral

Bioventix has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than Bioventix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Silence Therapeutics£11.35M0.00N/A-£48.60N/A
Bioventix£13.66M8.99£8.12M£1.481,587.56

Summary

Bioventix beats Silence Therapeutics on 8 of the 8 factors compared between the two stocks.

Get Bioventix News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVXP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BVXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVXP vs. The Competition

MetricBioventixBiotechnology IndustryMedical SectorLON Exchange
Market Cap£122.87M£222.70M£6.02B£2.59B
Dividend Yield6.54%3.81%5.73%5.32%
P/E Ratio1,587.5698.9685.124,390.72
Price / Sales8.995,693.57589.92101,116.96
Price / Cash30.8913.1925.7727.90
Price / Book10.23106.1212.678.01
Net Income£8.12M-£90.99M£3.32B£5.89B
7 Day Performance-2.22%-0.28%0.50%0.11%
1 Month Performance-3.94%4.24%9.42%1.93%
1 Year Performance-38.92%736.29%79.11%142.77%

Bioventix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVXP
Bioventix
N/AGBX 2,351.50
-1.0%
N/A-39.6%£122.87M£13.66M1,587.5612
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
PRTC
PureTech Health
1.5487 of 5 stars
GBX 140.80
+1.3%
GBX 455
+223.2%
-12.3%£340.29M£6.17M828.24300
HZD
Horizon Discovery Group plc (HZD.L)
N/AN/AN/AN/A£302.98M£54.63M-33.55416
AVCT
Avacta Group
2.4032 of 5 stars
GBX 62.50
+1.6%
GBX 99
+58.4%
+22.2%£251.10M£113K-407.43120News Coverage
Analyst Forecast
VRP
Verona Pharma plc (VRP.L)
N/AN/AN/AN/A£228MN/A-1.6822Gap Up
FARN
Faron Pharmaceuticals Oy
N/AGBX 185
+2.8%
N/A-16.9%£207.12MN/A-685.1934Gap Down
High Trading Volume
ARIX
Arix Bioscience
N/AN/AN/AN/A£183.73M£14.16M1,290.919
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
4BB
4basebio
1.4902 of 5 stars
GBX 750.50
-3.2%
GBX 1,600
+113.2%
-46.0%£116.22M£933K-798.40101Positive News
Gap Down
TILS
Tiziana Life Sciences
N/AN/AN/AN/A£113.85M-£3.60M-3.5911

Related Companies and Tools


This page (LON:BVXP) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners